Last update 21 May 2026

TSC-201 (HLA-A*24:02)

Overview

Basic Info

Drug Type
TCR-T Cell therapy
Synonyms
TSC 201 (HLA-A*24:02), TSC-201 (HLA-A*24:02)
Target
MAGEC2
Action
antagonists
Mechanism
MAGEC2 antagonists(MAGE family member C2 antagonists), Immunologic cytotoxicity, T lymphocyte replacements
Therapeutic Areas
NeoplasmsDigestive System DisordersRespiratory Diseases+ [1]
Active Indication-
Inactive Indication
Anus NeoplasmsHead and Neck NeoplasmsNon-Small Cell Lung Cancer+ [2]
Originator Organization
TScan Therapeutics, Inc.TScan Therapeutics, Inc.
Active Organization-
Inactive Organization
TScan Therapeutics, Inc.TScan Therapeutics, Inc.
License Organization-
Drug Highest PhaseDiscontinuedPreclinical
First Approval Date-
Regulation-

Related

100 Clinical Results associated with TSC-201 (HLA-A*24:02)
Login to view more data
100 Translational Medicine associated with TSC-201 (HLA-A*24:02)
Login to view more data
100 Patents (Medical) associated with TSC-201 (HLA-A*24:02)
Login to view more data
100 Deals associated with TSC-201 (HLA-A*24:02)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Anus NeoplasmsPreclinical
United States
TScan Therapeutics, Inc.TScan Therapeutics, Inc.
01 Dec 2024
Head and Neck NeoplasmsPreclinical
United States
TScan Therapeutics, Inc.TScan Therapeutics, Inc.
01 Dec 2024
Non-Small Cell Lung CancerPreclinical
United States
TScan Therapeutics, Inc.TScan Therapeutics, Inc.
01 Dec 2024
SarcomaPreclinical
United States
TScan Therapeutics, Inc.TScan Therapeutics, Inc.
01 Dec 2024
Uterine Cervical CancerPreclinical
United States
TScan Therapeutics, Inc.TScan Therapeutics, Inc.
01 Dec 2024
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free